Ads
related to: multiple sclerosis treatment
Search results
D.C.’s Vanda Pharmaceuticals rejects acquisition offer — again - Washington Business Journal
The Business Journals· 6 days agoVanda Pharmaceuticals Inc. (NASDAQ: VNDA) has rejected an unsolicited acquisition proposal that...
49-year-old charged with vehicular homicide after multi-vehicle wreck in Green County, KSP says
WDRB 41 Louisville News· 2 days agoLarry Waters, 49, was arrested and charged with vehicular homicide after the crash on West Buckner...
Brain Health Compromised by Climate Change
MedPage Today· 7 days agoClimate change will continue to affect brain health, researchers predicted. "The scale of potential effects of climate change on neurological diseases is likely to be substantial," wrote epilepsy ...
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference
Digital Journal· 2 days agoNEWTOWN, PA / ACCESSWIRE / May 31, 2024 / Helius Medical Technologies, Inc., (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation ...
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in...
The Joplin Globe· 7 days agoTORONTO, ON / ACCESSWIRE / May 28, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days ago"This milestone completes the transfer of the FDA marketing authorization to Vanda and allows Vanda to commence full commercialization efforts and begin clinical development programs as we seek ...
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
Clearfield Progress· 4 days ago"This milestone completes the transfer of the FDA marketing authorization to Vanda and allows Vanda to commence full commercialization efforts and begin clinical development programs as we seek ...
Barriers to MS Care in Underrepresented Communities
Medscape· 7 days agoFor today's Care Cues segment, we're going to be talking about physician-patient communication, with a focus on underrepresented communities in medicine....
May is Better Speech and Hearing Month - The Advocate-Messenger
The Danville Advocate-Messenger· 6 days agoDo you find yourself coughing or throat clearing when eating and drinking? Do you have a wet or...
Cantargia ASCO Presentation Highlights Positive Clinical Data on Nadunolimab Counteracting...
Digital Journal· 2 days agoCantargia is listed on Nasdaq Stockholm (ticker: CANTA). More...immune suppressive tumor microenvironment and development of resistance to chemotherapy. Nadunolimab is investigated in